Lexagene Holdings (LXG) has notable insider buying
Lexagene Holdings (V:LXG)
Updated Friday Jun 02, 2017 02:10 AM EDT
Daryl Rebeck, a Director, acquired 50,000 Common Shares on a direct ownership basis at a price of $0.680 through the public market on May 30th, 2017. This represents a $34,000 investment into the company's shares and an account share holdings change of 1.0%.LexaGene Holdings Inc, formerly Wolfeye Resource Corp, is a Canada-based biotechnology company. The Company focuses on building automated instruments for rapid pathogen detection. The Company's instrument operates a layperson, allowing the Company to place these instruments at the site of collection, whether inside of food processing plants or inside hospitals.
Headlines: Jun 02, 2017
LXG Insider Holdings Chart
Issuer details as of Jun 02, 2017 2:10 ET
Latest Price
0.70
1 Day Change
0.00%
52 Week High
0.99
52 Week Low
0.225
QMV ($Mils)
35,283,922